353 related articles for article (PubMed ID: 24797169)
1. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.
Marín M; Gudiol C; Garcia-Vidal C; Ardanuy C; Carratalà J
Medicine (Baltimore); 2014 May; 93(3):143-149. PubMed ID: 24797169
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
3. Current etiology, clinical features and outcomes of bacteremia in older patients with solid tumors.
Antonio M; Gudiol C; Royo-Cebrecos C; Grillo S; Ardanuy C; Carratalà J
J Geriatr Oncol; 2019 Mar; 10(2):246-251. PubMed ID: 30005979
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection.
Marín M; Gudiol C; Ardanuy C; Garcia-Vidal C; Jimenez L; Domingo-Domenech E; Pérez FJ; Carratalà J
Clin Microbiol Infect; 2015 Jun; 21(6):583-90. PubMed ID: 25680311
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections in patients with solid tumors.
Gudiol C; Aguado JM; Carratalà J
Virulence; 2016 Apr; 7(3):298-308. PubMed ID: 26787095
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
[TBL] [Abstract][Full Text] [Related]
7. Characteristics, aetiology, antimicrobial resistance and outcomes of bacteraemic cholangitis in patients with solid tumours: A prospective cohort study.
Royo-Cebrecos C; Gudiol C; García J; Tubau F; Laporte J; Ardanuy C; Antonio M; Marin M; Gornals JB; Carratalà J
J Infect; 2017 Feb; 74(2):172-178. PubMed ID: 27826062
[TBL] [Abstract][Full Text] [Related]
8. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Del Río A; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
Clin Microbiol Infect; 2019 Apr; 25(4):447-453. PubMed ID: 30096417
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines.
Puerta-Alcalde P; Chumbita M; Charry P; Castaño-Díez S; Cardozo C; Moreno-García E; Marco F; Suárez-Lledó M; Garcia-Pouton N; Morata L; Fernández-Avilés F; Martínez-Roca A; Rodríguez G; Martínez JA; Martínez C; Mensa J; Urbano Á; Rovira M; Soriano A; Garcia-Vidal C
Transplant Cell Ther; 2021 Jun; 27(6):501.e1-501.e6. PubMed ID: 33891882
[TBL] [Abstract][Full Text] [Related]
10. Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
Gudiol C; Albasanz-Puig A; Laporte-Amargós J; Pallarès N; Mussetti A; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Paz Morales H; Brunel AS; García E; Isler B; Kern WV; Morales I; Maestro-de la Calle G; Montero M; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J;
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015035
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
Bodro M; Gudiol C; Garcia-Vidal C; Tubau F; Contra A; Boix L; Domingo-Domenech E; Calvo M; Carratalà J
Support Care Cancer; 2014 Mar; 22(3):603-10. PubMed ID: 24170166
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single-center experience.
Shendi AM; Wallis G; Painter H; Harber M; Collier S
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29151282
[TBL] [Abstract][Full Text] [Related]
13. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
15. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
[TBL] [Abstract][Full Text] [Related]
16. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
[TBL] [Abstract][Full Text] [Related]
17. Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
Chumbita M; Puerta-Alcalde P; Yáñez L; Cuesta MA; Chinea A; Español Morales I; Fernández Abellán P; Gudiol C; Guerreiro M; González-Sierra P; Rojas R; Sánchez Pina JM; Sánchez Vadillo I; Varela R; Vázquez L; Lopera C; Monzó P; Garcia-Vidal C
J Antimicrob Chemother; 2022 Jun; 77(7):2017-2023. PubMed ID: 35466357
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J
Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973
[TBL] [Abstract][Full Text] [Related]
19. Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study.
Oriol I; Sabé N; Simonetti AF; Lladó L; Manonelles A; González J; Tubau F; Carratalà J
Transpl Int; 2017 Sep; 30(9):903-913. PubMed ID: 28500792
[TBL] [Abstract][Full Text] [Related]
20. Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms.
Saliba M; Saadeh D; Bouchand F; Davido B; Duran C; Clair B; Lawrence C; Annane D; Denys P; Salomon J; Bernard L; Dinh A
Spinal Cord; 2017 Feb; 55(2):148-154. PubMed ID: 27995941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
